For a complete list see Google Scholar profile.

Samur MK, Roncador M, Aktas Samur A, Fulciniti M, Bazarbachi A, Szalat R, Shammas MA, Sperling AS, Richardson PG, Magrangeas F, Minvielle S, Perrot A, Corre J, Moreau P, Thakurta A, Parmigiani G, Anderson KC, Avet-Loiseau H, Munshi NC, High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma, Blood (2023) 141 (14): 1724-1736.

Morelli E, Fulciniti M, Samur M, Ribeiro C, Wert-Lamas L, Henninger J, Gulla A, Aktas Samur A, Katia Todoerti, Srikanth Talluri, Park W, Federico C, Scionti F, Amodio N, Bianchi G, Johnstone M, Liu N, Gramegna D, Maisano D, Russo N, Lin C, Tai YT, Neri A,Chauhan D, Hideshima T, Shammas M, Tassone P, Gryaznov S, Young R, Anderson K, Novina C, Loda M, Munshi N, A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth, Blood (2023) 141 (4): 391–405.

Aktas-Samur A, Fulciniti M, Avet-Loiseau H, Lopez M, Derebail S, Corre J, Minvielle S, Magrengaes F, Moreau P, Anderson K, Parmigiani G, Samur, MK, Munshi NC. In-Depth Analysis of Alternative Splicing Landscape in Multiple Myeloma and Potential Role of Dysregulated Splicing Factors, Blood Cancer Journal, Dec 20, 2022, volume: 12, p:1-11

Bazarbachi A, Avet-Loiseau H , Szalat R , Aktas Samur A, Hunter Z , Shammas M, Corre J , Fulciniti M , Anderson KC , Parmigiani G , Treon SP , Mohty M , Munshi NC , Samur MK, IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM, Blood 2021 Nov 18;138(20):1980-1985, doi: 10.1182/blood.2021011452

Bianchi G, Czarnecki P , Ho M , Roccaro A , Sacco A, Kawano Y, Gullà A ,Aktas Samur A, Chen T, Wen K , Tai Y , Moscvin M , Wu X , Camci-Unal G, Claudio Da Vià M, Bolli N ,Carrasco D , Ghobrial I , Anderson K. Roundabout 1 (ROBO1) Mediates Homing, Dissem-ination, and Survival of Multiple Myeloma Cells within the Bone Marrow Microenvi-ronment, Blood Cancer Discovery , April 10 2021 DOI:10.1158/2643-3230.BCD-20-0164

Samur M, Fulciniti M, Aktas Samur A, Bazarbachi AH, Tai Y, Prabhala R, Alonso A, Sperling A, Campbell T, Petrocca F, Hege K, Kaiser S, Avet-Loiseau H, Anderson K, and Munshi N, Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with Multiple Myeloma, Nat Commun. 2021 Feb 8;12(1):868.doi: 10.1038/s41467-021-21177-5.

Samur, MK, Aktas Samur A, Fulciniti M, Szalat R,Han T, Shammas M, Richardson P, Magrengaes F, Minvielle S, Corre J, Moreau P, Thakurta A, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC. Genome Wide Somatic Alterations in Multiple Myeloma Reveals a Superior Outcome Group, J Clin Oncol. 2020 Sep 20;38(27):3107-3118. doi: 10.1200/JCO.20.00461

Aktas Samur A, Minvielle S, Shammas M, Fulciniti M, Magrangeas F, Richardson PG, Moreau P, 
Attal M, Anderson KC, Parmigiani G, Avet-Loiseau H, Munshi NC, Samur MK.
Deciphering the chronology of copy number alterations in Multiple Myeloma,
Blood Cancer J. 2019 Mar 26;9(4):39. doi: 10.1038/s41408-019-0199-3.